You are here: Industry Insights > Market News > Congo declares new Ebola outbreak

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

Congo declares new Ebola outbreak

biospectrumasiaAugust 03, 2018

Tag: Ebola , hemorrhagic fevers , virus

Favorites

Four people have tested positive for Ebola in eastern Democratic Republic of Congo just a week after another outbreak that killed 33 people in the northwest was declared over.

Twenty people have already died from hemorrhagic fevers in and around Mangina. The area also has strong trade with neighboring Rwanda and Uganda, raising the risk of the virus moving internationally.

-----------------------------------------------------------------------------------------------------------------------------

Editor's Note:

To apply for becoming a contributor of en-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

Previous:Applied DNA reaches new milestones

Next:Medpacto inks deal with AstraZeneca

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Congo declares new Ebola outbreak | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)

Virus Sampling Tube Machine

FiltraLinX® Virus Filter Holder

TDZ5 2021 virus detection centrifuge for Pharmaceutical

Entecavir 99%min Pharmaceutical Nucleoside Antivirus products made in china

IPV(Inactivated Poliovirus Vaccine)

double virus inactivation Human Immunoglobulin (pH4) for Intravenous Injection

3ml5ml nucleic acid detection bottle reagent bottle virus sampling tube plastic extraction tube drop

Arbidol hydrochloride 99%min Pharmaceutical API Antibacterial and anti inflammation Anti virus made

Human Rhinovirus-14 (HRV14) Protease Substrates

Congo declares new Ebola outbreak

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>